Over 300 international participants attended the scientific meeting “100 years Ewing Sarcoma: Learnings from the past, Challenges for the future”.
Over the course of the two-day conference, we took a look on what has been achieved in Ewing Sarcoma so far, what the Status Quo of Ewing management currently is and where the future might take us.
The meeting was held to honor the “Cancer Man” James Ewing, who did not only describe the “Ewing Sarcoma” but was a founder of what is today the American Cancer Society and laid the foundation of today`s Memorial Sloan Kettering Cancer Centre. He was an oncologist by heart. This meeting was a great opportunity to come together and reflect upon the past in Ewing Sarcoma but also look towards the future as a global community.
Recordings of the sessions
100 Years Ewing Sarcoma: Welcome and Introduction |
100 Years Ewing Sarcoma: A Journey through time |
100 Years Ewing Sarcoma: Status Quo of treatment and care: Lessons learned |
100 Years Ewing Sarcoma: Basic Research - News and Updates/Young Scientists (Part 1) |
100 Years Ewing Sarcoma: Basic Research: News and Updates/Young Scientists (Part 2) |
100 years Ewing Sarcomas: Relapse - new ideas and innovations from bench to bedside |
100 Years Ewing Sarcoma: A powerful partnership: Experts and Patient Advocates |
100 Years Ewing Sarcoma: Local therapy options: What's new? |
100 Years Ewing Sarcoma: From Junior to Senior - Ewings in all ages and AYA-cancer |
100 Years Ewing Sarcoma: Late effects and Quality of Life |
Program
See the “100 years Ewing Sarcoma: Learnings from the past, Challenges for the future” program here
>> pdf download of the program here
For any questions, please contact email: यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.
Support and Funding
This meeting is financially supported by:
We thank all our sponsors for their kind support!
"100 years Ewing Sarcoma Meeting" at a glance
Date: | Friday, 10th of December from 12:30 CET until Saturday, 11th of December around 14:00 CET |
Organizer: | Univ.-Prof. Dr. med. Uta Dirksen, University Hospital Essen, Germany, PD Dr. med. Peter Reichardt, Helios Hospital Berlin-Buch, Germany, Chair of the Board of the German Sarcoma Foundation Markus Wartenberg, Deputy Chair of the Board of the German Sarcoma Foundation, Chair of the Board of Sarcoma Patients EuroNet (SPAEN) Deutsche Sarkom-Stiftung (= gemeinnützige Stiftung) Sarcoma Patients EuroNet (SPAEN) |
Place of event: | Online via Zoom |
Conference language: | English |
CME-Certification: | Through "Landesärztekammer" Essen |
Sponsor-Partner: | Bayer, Eli Lilly, Implantcast, Luttermann, Medac, Roche Pharma |
GIST
Gastrointestinal stromal tumor (GIST) affects the digestive tract or nearby structures within the abdomen. The most common location is the stomach. GI stromal tumor, or GIST cancer, is a sarcoma.